Abstract:Objective:This study aims to investigate the expression pattern of miR-512-3p in breast cancer and noncancerous paired specimens as well as the effects of miR-512-3p on the proliferation, apoptosis, cell cycle, and cloning of MD-MBA-231 breast cancer cells. The study also aims to identify the miR-512-3p target gene. Methods:Reverse transcription-polymerase chain reaction (RT-PCR) was conducted to quantify the miR-512-3p expression in breast cancer and noncancerous paired specimens. Methylthiazol tetrazolium (MTT) assay, flow cytometry, and clone formation assay were used to characterize the function of miR-512-3p in breast cancer. Target prediction was performed using the TargetScan, PicTar, and miRanda software. The results were validated using RT-PCR and western blot target validation. Results:The relative expression of miR-512-3p in breast cancer specimens was significantly lower than those in normal breast specimens (P<0.05). MTT assay revealed that 48 h after transfection, miR-512-3p significantly repressed the proliferation of MD-MBA-231 cells at a suppression rate of 45.38%and at a concentration of 100 nmol/L. MiR-512-3p increased the percentage of early apoptotic cells in the treatment groups (9.32 ± 0.41)%compared with those in the blank controls (3.1 ± 0.54)%and in the negative controls (2.9 ± 0.39)%(P<0.05). Significant differences were found in the percentages of the G0/G1-and G2/M-phase cells after miR-512-3p transfection compared with those in the controls (P<0.05). In the cloning assay, clone formation was inhibited in the miR-512-3p-transfected groups compared with those in the control groups. RT-PCR and western blot results indicate that miR-512-3p significantly inhibited the c-FLIP mRNA and protein expression. Conclusion:MiR-512-3p expression is relatively decreased in breast cancer specimens compared with those in the normal samples. The negative effect of miR-512-3p on cell proliferation and clone formation and its positive effect on early apoptosis through c-FLIP targeting suggest that miR-512-3p acts as a tumor suppressor gene in breast cancer. Therefore, miR-512-3p may be a new target for the diagnosis and treatment of breast cancer in the future.

MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

High Expression of Microrna-183/182/96 Cluster As A Prognostic Biomarker for Breast Cancer

Dysregulation and Functional Roles of Mir-183-96-182 Cluster in Cancer Cell Proliferation, Invasion and Metastasis

Mir-221/222 Promotes S-phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer.

MicroRNA-183 in Cancer Progression

MiR-512-3p Expression Pattern and Function in Breast Cancer

Amplification of Hsa-Mir-191/425 Locus Promotes Breast Cancer Proliferation and Metastasis by Targeting DICER1

Autocrine Hgh Stimulated Mirna 96‐182‐183 Cluster Promotes Epithelial‐mesenchymal Transition and Invasion in Breast Cancer (LB201)

Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer

Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review)

Mir-3646 Promotes Cell Proliferation, Migration, and Invasion Via Regulating G2/M Transition in Human Breast Cancer Cells.

Mir-135b, Upregulated in Breast Cancer, Promotes Cell Growth and Disrupts the Cell Cycle by Regulating Lats2

Mir-96 Promotes Cell Proliferation, Migration and Invasion by Targeting PTPN9 in Breast Cancer.

MiR-218-5p&nbsp;promotes breast cancer progression via LRIG1

Unregulated Mir-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor Foxo3a

HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer

HIC1 and miR-23 similar to 27 similar to 24 clusters form a double-negative feedback loop in breast cancer

MiR-96-5p Promotes Breast Cancer Migration by Activating MEK/ERK Signaling.

Tumor Suppressive Microrna-193B Promotes Breast Cancer Progression Via Targeting DNAJC13 and RAB22A.

miRNA Clusters with Up-Regulated Expression in Colorectal Cancer

miR-301b-3p Regulates Breast Cancer Cell Proliferation, Migration, and Invasion by Targeting NR3C2